ConductScience.org, home

Paper2821152

Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.

Richman DD and 2 others. J Exp Med, 1987. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages. Papers, record 2821152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2821152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
PubMed
Journal
J Exp Med
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
141
iCite
Relative citation ratio, by iCite
4.01
iCite
Revised in PubMed
2019-05-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richman DDD D
2Kornbluth RSR S
3Carson DAD A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DeoxyadenosinesMajor topic
DeoxycytidineMajor topic
HIVMajor topic
MacrophagesMajor topic
ThymidineMajor topic
Virus ReplicationMajor topic
Adenosine Kinase
Cell Line
Deoxycytidine Kinase
Dideoxyadenosine
Humans
Phosphorylation
T-Lymphocytes
Thymidine Kinase
Uridine Kinase
Zalcitabine
Zidovudine

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-52578NIAID NIH HHSUnited StatesN01AI052578PubMed and NIHNIH RePORTER
AI/CA-24466NIAID NIH HHSUnited StatesPubMedPubMed
HL-32471NHLBI NIH HHSUnited StatesR01HL032471PubMed and NIHNIH RePORTER
R01AI024466NIHNIH RePORTER

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1942051A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976https://conductscience.org/library/papers/942051PubMed
23299090The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.N Engl J Med1987https://conductscience.org/library/papers/3299090PubMed
3458147The regulation of thymidine secretion by macrophages.J Immunol1979https://conductscience.org/library/papers/458147PubMed
47085768Deoxycytidine excretion by mouse peritoneal macrophages: its implication in modulation of immunological functions.J Cell Physiol1982https://conductscience.org/library/papers/7085768PubMed
56875265Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes.J Immunol Methods1983https://conductscience.org/library/papers/6875265PubMed
66542017Production of the effector molecule thymidine by human lung alveolar macrophages.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6542017PubMed
76096719The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.Nature1984https://conductscience.org/library/papers/6096719PubMed
86083454T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.Nature1984https://conductscience.org/library/papers/6083454PubMed
92992081Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.Science1985https://conductscience.org/library/papers/2992081PubMed
1024134593'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2413459PubMed
112869302Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.Lancet1986https://conductscience.org/library/papers/2869302PubMed
123006077Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3006077PubMed
132422213Infection of monocyte/macrophages by human T lymphotropic virus type III.J Clin Invest1986https://conductscience.org/library/papers/2422213PubMed
143014648The role of mononuclear phagocytes in HTLV-III/LAV infection.Science1986https://conductscience.org/library/papers/3014648PubMed
153015143Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.Biochem Pharmacol1986https://conductscience.org/library/papers/3015143PubMed
163016903Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.Science1986https://conductscience.org/library/papers/3016903PubMed
173018755Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3018755PubMed
183532930Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.Ann Neurol1986https://conductscience.org/library/papers/3532930PubMed
193639952Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement.JAMA1986https://conductscience.org/library/papers/3639952PubMed
203490587Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.JAMA1986https://conductscience.org/library/papers/3490587PubMed

See all 24 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
31505928Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-Glycoprotein with Anti-HIV-1 Activity.J Med Chem2020https://conductscience.org/library/papers/31505928PubMed
21866921Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.J Am Chem Soc2012https://conductscience.org/library/papers/21866921PubMed
19349849Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses.AIDS2009https://conductscience.org/library/papers/19349849PubMed
15163710Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.J Virol2004https://conductscience.org/library/papers/15163710PubMed
8633079Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8633079PubMed
8452370Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophages.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8452370PubMed
8322167The design and development of an immunosuppressive drug, mycophenolate mofetil.Springer Semin Immunopathol1993https://conductscience.org/library/papers/8322167PubMed
7915097Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7915097PubMed
7910722Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7910722PubMed
7686460Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).Drugs1993https://conductscience.org/library/papers/7686460PubMed
3501941Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3501941PubMed
3067915The future of antiviral chemotherapy.Dermatol Clin1988https://conductscience.org/library/papers/3067915PubMed
2844951Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.J Exp Med1988https://conductscience.org/library/papers/2844951PubMed
2680436Antiviral therapy in human immunodeficiency virus infection.Drugs1989https://conductscience.org/library/papers/2680436PubMed
2538549
Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
J Exp Med1989https://conductscience.org/library/papers/2538549PubMed
2466937Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.J Exp Med1989https://conductscience.org/library/papers/2466937PubMed
2458483Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication.J Virol1988https://conductscience.org/library/papers/2458483PubMed
2334156Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2334156PubMed
2212939Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.J Exp Med1990https://conductscience.org/library/papers/2212939PubMed
2167039In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2167039PubMed

See all 25 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADK132PubTator's text mininghttps://conductscience.org/library/genes/132NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
DCK1633PubTator's text mininghttps://conductscience.org/library/genes/1633NCBI Gene
UCK27371PubTator's text mininghttps://conductscience.org/library/genes/7371NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2821152

GET https://conductscience.org/api/papers/v1/2821152/references?page=2